MAM
CRDF icon

Meeder Asset Management’s Cardiff Oncology CRDF Stock Holding History

Meeder Asset Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-376
Closed -$1.74K – 1570
2018
Q2 		$1.74K Buy
376
+301
+401% +$5.03K ﹤0.01% 1435
2018
Q1 		$2K Hold
75
– – ﹤0.01% 1370
2017
Q4 		$2K Buy
75
+39
+108% +$1.73K ﹤0.01% 1483
2017
Q3 		$2K Buy
36
+14
+64% +$873 ﹤0.01% 1443
2017
Q2 		$2K Buy
22
+7
+47% +$451 ﹤0.01% 1391
2017
Q1 		$1K Sell
15
-71
-83% -$9.64K ﹤0.01% 1497
2016
Q4 		$13K Buy
+86
New +$20.1K ﹤0.01% 708

Other funds holding CRDF

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return